Settin Ahmad, El-Bendary Mahmoud, Abo-Al-Kassem Rabab, El Baz Rizk
Manosura University Children Hospital, Mansoura, Egypt.
J Gastrointestin Liver Dis. 2006 Jun;15(2):131-5.
Alpha-1-antitrypsin (A1AT) S and Z deficiency alleles and hemochromatosis (HFE) mutant C282Y, H63D alleles were reported to potentially affect the liver even if present in a heterozygous state.
This is a cross-sectional, randomized, case controlled study for evaluation of the frequency of these alleles in Egyptian patients with HCV liver cirrhosis and of their association with the disease.
This study included 48 cases with viral C cirrhosis recruited from the Hepatology Unit, Mansoura University Hospital, Egypt, and 70 unrelated healthy controls.
PCR amplification of relevant gene segment followed by restriction enzyme digestion Taq1 for detection of A1AT gene S and Z alleles, digestion with Rsa I and Bcl I for HFE gene C282Y and H63D alleles. These alleles were then characterized through analysis of resulting restriction fragment length polymorphism (RFLP).
Both heterozygous (MS) and homozygous (SS) genotypes were significantly more frequent in cases than in controls ( P<0.05, RR= 2.23 and 2.17 respectively). Gene frequency of S allele was higher in cases than controls (P<0.05, RR=2.17). Homozygosity (ZZ) genotype, present only in cases (6.3% vs 0.0% in controls,) did not reach statistical significance. HFE gene heterozygosity for H63D allele was detected in 20.0% of cases and 21.4% of controls, whereas C282Y allele was detected neither among cases nor in controls.
The presence of the relatively high frequency of A1AT S and HFE H63D allele carriers in Egyptian cases of HCV liver cirrhosis suggest the necessity to implement routine molecular analysis of these genes for detection of risk genotypes among affected families.
据报道,α1抗胰蛋白酶(A1AT)S和Z缺陷等位基因以及血色素沉着症(HFE)突变C282Y、H63D等位基因即使以杂合状态存在,也可能影响肝脏。
这是一项横断面、随机、病例对照研究,旨在评估这些等位基因在埃及丙型肝炎肝硬化患者中的频率及其与疾病的关联。
本研究纳入了48例从埃及曼苏拉大学医院肝病科招募的病毒性C型肝硬化患者,以及70名无关的健康对照者。
对相关基因片段进行PCR扩增,随后用Taq1限制性内切酶消化以检测A1AT基因S和Z等位基因,用Rsa I和Bcl I消化以检测HFE基因C282Y和H63D等位基因。然后通过分析所得的限制性片段长度多态性(RFLP)对这些等位基因进行鉴定。
杂合子(MS)和纯合子(SS)基因型在病例组中的频率均显著高于对照组(P<0.05,RR分别为2.23和2.17)。病例组中S等位基因的基因频率高于对照组(P<0.05,RR=2.17)。仅在病例组中出现的纯合子(ZZ)基因型(6.3% vs对照组为0.0%)未达到统计学意义。在20.0%的病例组和21.4%的对照组中检测到HFE基因H63D等位基因的杂合性,而在病例组和对照组中均未检测到C282Y等位基因。
在埃及丙型肝炎肝硬化病例中,A1AT S和HFE H63D等位基因携带者的频率相对较高,这表明有必要对这些基因进行常规分子分析,以在受影响的家族中检测风险基因型。